Wassil Merrouche

7.5k total citations · 2 hit papers
43 papers, 5.7k citations indexed

About

Wassil Merrouche is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Wassil Merrouche has authored 43 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Epidemiology, 32 papers in Hepatology and 5 papers in Surgery. Recurrent topics in Wassil Merrouche's work include Liver Disease Diagnosis and Treatment (39 papers), Hepatitis C virus research (18 papers) and Liver Disease and Transplantation (15 papers). Wassil Merrouche is often cited by papers focused on Liver Disease Diagnosis and Treatment (39 papers), Hepatitis C virus research (18 papers) and Liver Disease and Transplantation (15 papers). Wassil Merrouche collaborates with scholars based in France, Hong Kong and Italy. Wassil Merrouche's co-authors include Victor de Lédinghen, Juliette Foucher, Julien Vergniol, Brigitte Le Bail, Patrice Couzigou, Pierre–Henri Bernard, Laurent Castéra, Vincent Wai‐Sun Wong, Grace Lai–Hung Wong and Anthony W.H. Chan and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Wassil Merrouche

42 papers receiving 5.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnosis of Fibrosis and Cirrhosis Using Liver Stiffness Measurement in Nonalcoholic Fatty Liver Disease

2009 1.0k citations Vincent Wai‐Sun Wong, Julien Vergniol et al. Hepatology profile →
Pitfalls of Liver Stiffness Measurement: A 5-Year Prospective Study of 13,369 Examinations

2009 922 citations Laurent Castéra, Juliette Foucher et al. Hepatology profile →

Peers

Wassil Merrouche

EPIDE

HEPAT

EDM

SURGE

Julien Vergniol France

Juliette Foucher France

Umberto Arena Italy

Christos Christidis France

Frédéric Mal France

Anaïs Vallet‐Pichard France

Eduardo Lissen Spain

Catherine Douvin France

M. Sasso France

Chien‐Wei Su Taiwan

Julien Vergniol France

Wassil Merrouche

6.8k ×1.3

EPIDE

5.3k ×1.3

HEPAT

911 ×1.1

EDM

862 ×1.2

SURGE

366 ×1.2

Citations per year, relative to Wassil Merrouche Wassil Merrouche (= 1×) peers Julien Vergniol

Countries citing papers authored by Wassil Merrouche

Since Specialization

Citations

This map shows the geographic impact of Wassil Merrouche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wassil Merrouche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wassil Merrouche more than expected).

Fields of papers citing papers by Wassil Merrouche

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wassil Merrouche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wassil Merrouche. The network helps show where Wassil Merrouche may publish in the future.

Co-authorship network of co-authors of Wassil Merrouche

This figure shows the co-authorship network connecting the top 25 collaborators of Wassil Merrouche. A scholar is included among the top collaborators of Wassil Merrouche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wassil Merrouche. Wassil Merrouche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mustapha, Nik Raihan Nik, Grace Lai–Hung Wong, Sanjiv Mahadeva, et al.. (2019). Performance of Simple Fibrosis Scores in Nonobese Patients With Nonalcoholic Fatty Liver Disease. Clinical Gastroenterology and Hepatology. 18(12). 2843–2845.e2. 22 indexed citations

Lédinghen, Victor de, Jean‐Baptiste Hiriart, Julien Vergniol, et al.. (2017). Controlled Attenuation Parameter (CAP) with the XL Probe of the Fibroscan®: A Comparative Study with the M Probe and Liver Biopsy. Digestive Diseases and Sciences. 62(9). 2569–2577. 77 indexed citations

Wong, Vincent Wai‐Sun, Salvatore Petta, Jean‐Baptiste Hiriart, et al.. (2017). Validity criteria for the diagnosis of fatty liver by M probe-based controlled attenuation parameter. Journal of Hepatology. 67(3). 577–584. 111 indexed citations

Vergniol, Julien, Jérôme Boursier, Clélia Coutzac, et al.. (2014). Evolution of Noninvasive Tests of Liver Fibrosis Is Associated With Prognosis in Patients With Chronic Hepatitis C. Hepatology. 60(1). 65–76. 92 indexed citations

Lédinghen, Victor de, Julien Vergniol, Maylis Capdepont, et al.. (2014). Controlled attenuation parameter (CAP) for the diagnosis of steatosis: A prospective study of 5323 examinations. Journal of Hepatology. 60(5). 1026–1031. 290 indexed citations

Martínez, Stella Maris, Juliette Foucher, Sophie Métivier, et al.. (2012). Longitudinal Liver Stiffness Assessment in Patients with Chronic Hepatitis C Undergoing Antiviral Therapy. PLoS ONE. 7(10). e47715–e47715. 53 indexed citations

Vergniol, Julien, Juliette Foucher, Éric Terrebonne, et al.. (2011). Noninvasive Tests for Fibrosis and Liver Stiffness Predict 5-Year Outcomes of Patients With Chronic Hepatitis C. Gastroenterology. 140(7). 1970–1979.e3. 302 indexed citations

Lédinghen, Victor de, Vincent Wai‐Sun Wong, Julien Vergniol, et al.. (2011). Diagnosis of liver fibrosis and cirrhosis using liver stiffness measurement: Comparison between M and XL probe of FibroScan®. Journal of Hepatology. 56(4). 833–839. 185 indexed citations

Castéra, Laurent, Pierre–Henri Bernard, Brigitte Le Bail, et al.. (2011). Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis B carriers. Alimentary Pharmacology & Therapeutics. 33(4). 455–465. 65 indexed citations

10.

Lédinghen, Victor de, Julien Vergniol, Juliette Foucher, et al.. (2010). Feasibility of liver transient elastography with FibroScan® using a new probe for obese patients. Liver International. 30(7). 1043–1048. 164 indexed citations

11.

Lédinghen, Victor de, Juliette Foucher, J. Vergniol, et al.. (2009). 989 NEW FIBROSCAN PROBE FOR OBESE PATIENTS. A PILOT STUDY OF FEASIBILITY AND PERFORMANCES IN PATIENTS WITH BMI ≥ 30 kg/m2. Journal of Hepatology. 50. S359–S359. 12 indexed citations

12.

Castéra, Laurent, Juliette Foucher, Pierre–Henri Bernard, et al.. (2009). 127 PREVALENCE AND FACTORS ASSOCIATED WITH LIVER STIFFNESS MEASUREMENT FAILURE AND UNRELIABLE RESULTS USING FIBROSCAN: A 5 YEAR EXPERIENCE IN 13369 EXAMINATIONS. Journal of Hepatology. 50. S52–S52. 5 indexed citations

13.

Foucher, Juliette, et al.. (2009). FibroScan used in street‐based outreach for drug users is useful for hepatitis C virus screening and management: a prospective study. Journal of Viral Hepatitis. 16(2). 121–131. 39 indexed citations

14.

Vergniol, J., Juliette Foucher, Laurent Castéra, et al.. (2009). Changes of non‐invasive markers and FibroScan values during HCV treatment. Journal of Viral Hepatitis. 16(2). 132–140. 97 indexed citations

15.

Breilh, Dominique, Juliette Foucher, Laurent Castéra, et al.. (2009). Impact of ribavirin plasma level on sustained virological response in patients treated with pegylated interferon and ribavirin for chronic hepatitis C. Alimentary Pharmacology & Therapeutics. 30(5). 487–494. 10 indexed citations

16.

Castéra, Laurent, Juliette Foucher, Pierre–Henri Bernard, et al.. (2009). Pitfalls of Liver Stiffness Measurement: A 5-Year Prospective Study of 13,369 Examinations. Hepatology. 51(3). 828–835. 922 indexed citations breakdown →

17.

Wong, Vincent Wai‐Sun, Julien Vergniol, Grace Lai–Hung Wong, et al.. (2009). Diagnosis of Fibrosis and Cirrhosis Using Liver Stiffness Measurement in Nonalcoholic Fatty Liver Disease. Hepatology. 51(2). 454–462. 1013 indexed citations breakdown →

18.

Castéra, Laurent, Brigitte Le Bail, Françoise Roudot‐Thoraval, et al.. (2008). Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: Comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores. Journal of Hepatology. 50(1). 59–68. 289 indexed citations

19.

Adhoute, Xavier, Juliette Foucher, David Laharie, et al.. (2008). Diagnosis of liver fibrosis using FibroScan and other noninvasive methods in patients with hemochromatosis: A prospective study. Gastroentérologie Clinique et Biologique. 32(2). 180–187. 69 indexed citations

20.

Lédinghen, V. de, Pablo Barreiro, Juliette Foucher, et al.. (2008). Liver fibrosis on account of chronic hepatitis C is more severe in HIV‐positive than HIV‐negative patients despite antiretroviral therapy. Journal of Viral Hepatitis. 15(6). 427–433. 77 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact